US FDA Makes Misinformation Correction Easier For Pharma

 
• By Sarah Karlin-Smith
Emoticon showing ok sign
New draft guidance okays companies skirting some FDA promotion rules to respond to online misinformation. • Source: Shutterstock

More from Marketing & Advertising

More from Compliance